In our initial double-blind , placebo-controlled trial , we randomly assigned patients who had idiopathic pulmonary fibrosis with mild-to-moderate impairment in pulmonary function to receive a three-drug regimen of prednisone , azathioprine , and acetylcysteine ; acetylcysteine alone ; or placebo .